Science Explorer Back to mapMap
Discussion
Researcher · Instituto de Salud Carlos III · Spain

María Martin‐Vicente

María Martin‐Vicente publishes mostly in Infectious Diseases, Epidemiology and Immunology, on topics such as COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Respiratory viral infections research.

ORCID 0000-0001-9148-1476 OpenAlex
World rank
#2,186,020
of 7,710,434 ranked researchers
Rank in Spain
#47,295
of 204,306
Works
37
Citations
990
Citations per work
26.8
h-index
14
i10-index 21Top 43% in Infectious Diseases
María Martin‐Vicente

What does María Martin‐Vicente research?

María Martin‐Vicente's work is mostly in Medicine (49%), Immunology and Microbiology (11%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 18 works · 49.1% of their workMedicine: 18 works · 49.1% of their workInfectious Diseases: 9 works · 25.5% of their workEpidemiology: 6 works · 15.1% of their workPulmonary and Respiratory Medicine: 2 works · 4.7% of their workNeurology: 1 works · 3.8% of their workEverything else: 12 works · 32.1% of their workLife Sciences: 7 works · 18.8% of their workImmunology and Microbiology: 4 works · 11.3% of their workImmunology: 4 works · 11.3% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 7.5% of their workMolecular Biology: 3 works · 7.5% of their workTHEIR WORKMaríaMartin‐Vicente37works
Life Sciences19%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1849.1%
  2. Everything else1232.1%
    1. Immunology and Microbiology411.3%
    2. Biochemistry, Genetics and Molecular Biology37.5%
  1. 1Infectious Diseases26% of their works
  2. 2Epidemiology15% of their works
  3. 3Immunology11% of their works
  4. 4Molecular Biology8% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe María Martin‐Vicente's research?

The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Epidemiology, Immune Response, Coronavirus, Vaccine, Clinical Characteristics and Thrombosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. ACE2 Receptor252 topics
  2. SARS-CoV-2252 topics
  3. Epidemiology243 topics
  4. Immune Response162 topics
  5. Coronavirus152 topics
  6. Vaccine152 topics
  7. Clinical Characteristics131 topic
  8. Thrombosis131 topic
  9. antibody121 topic
  10. spike protein121 topic
  11. Human Metapneumovirus81 topic
  12. Respiratory Syncytial Virus81 topic
  13. Pattern Recognition Receptors72 topics
  14. Innate Immunity41 topic
  15. NAFLD41 topic
  16. NASH41 topic
  17. Neurologic Manifestations41 topic
  18. Post-acute COVID-19 Syndrome41 topic
  19. Viral Infection41 topic
  20. Circovirus31 topic
  21. Inflammation31 topic
  22. Porcine Reproductive and Respiratory Syndrome Virus31 topic
  23. Toll-like Receptors31 topic

Where does María Martin‐Vicente work?

María Martin‐Vicente's main affiliation in the publication record is Instituto de Salud Carlos III, Spain.

How many publications and citations does María Martin‐Vicente have?

OpenAlex counts 37 works and 990 citations for María Martin‐Vicente, an h-index of 14, ranking #2,186,020 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about María Martin‐Vicente. Posts are plain text and can be reported.